Illumina Genotyping Solutions to Support Study of Inflammatory Bowel Disease
News Jan 14, 2006
Illumina, Inc. has announced that the NIDDK1 Inflammatory Bowel Disease (IBD) Genetics Consortium will utilize the Sentrix® HumanHap300 BeadChips and Infinium™ assay reagents to genotype over 2000 case-control samples for a genome-wide study designed to help identify genetic variants that increase susceptibility to Crohn's disease (CD).
Principal Investigator of the Data Coordinating Center, Judy Cho, M.D., Associate Professor of Medicine, Section of Gastroenterology at the University of Chicago Hospitals, is leading the IBD study.
Dr. Cho and colleagues have assembled a well-characterized collection of disease samples and will perform the data analysis.
One thousand control individuals will be typed as part of the study, and the control genotypes will be made available to the scientific community.
"We feel that the rapid release of individual level genotypes for control populations will benefit the community of scientists who are working on complex genetic diseases," stated Dr. Peter K. Gregersen, M.D., Head of the Robert S. Boas Center for Genomics and Human Genetics at The Feinstein Institute for Medical Research.
"We are delighted to work with the NIDDK IBD Genetics Consortium and Illumina to make these data available in the context of this project."
Dr. Gregersen and his team will conduct the sample genotyping on an automated Illumina BeadStation using the Sentrix HumanHap300 BeadChip that can query over 317,000 tagSNPs on a single microarray device.
The BeadChip is powered by Illumina's Infinium assay, which enables the intelligent selection and analysis of virtually any SNP in the genome.
"We're delighted that the NIDDK IBD Genetics Consortium has selected Illumina technologies for this important study," said Jay Flatley, Illumina President and CEO.
"We are also very pleased to work once again with Peter Gregersen and to support his vision for making control genotyping data available to the scientific community."
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE